FdaApplication

NDA 020291

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBOEHRINGER INGELHEIM PHARMACEUTICALS INC
application_typeNDA
approval_date1996-10-24

Products (1)

ProductActive ingredientStrengthDosage form
COMBIVENTALBUTEROL SULFATE; IPRATROPIUM BROMIDEEQ 0.09MG BASE/INH;0.018MG/INHAEROSOL, METERED;INHALATION

1 product